Study title:
Danazol prophylaxis for delivery in hereditary angioneurotic oedema (HAE) - Investigators : AN Boulos et al. - Br. J. Obstet. Gynaecol., 1994, 101(12), Dec. 1094-1095
- Publication in CER - No author - 06/1996 -Danazol prophylaxis for delivery in hereditary angioneurotic oedema (HAE) - Investigators : AN Boulos et al. - Br. J. Obstet. Gynaecol., 1994, 101(12), Dec. 1094-1095
- Publication in CER - No author - 06/1996 -
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Skin and Connective Tissue Diseases
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: DANAZOL |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|